Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

AI turns low-quality MRI scans into helpful heart images
A team of biomedical engineers, radiologists and cardiologists has developed a new AI model capable of restoring low-quality cardiac MRI scans.
Johnson & Johnson MedTech faces threat of permanent injunction after losing antitrust case
After being ordered to pay $442 million in damages—a ruling the company has said it may appeal—Johnson & Johnson MedTech is now facing the possibility of a permanent injunction that could impact certain business practices. A hearing is scheduled for July.
Cardiologists, radiologists and surgeons share ‘landmark’ document on assessing prosthetic heart valves with CT
RSNA and several other industry societies have shared a new expert consensus document on the significant value of cardiac CT. Echo remains an effective first-line imaging option, the groups wrote, but CT can make a big impact as well.
AMA resolution backs expanded low-dose CT screenings for lung cancer, heart risk
Dana Smetherman, MD, CEO of the American College of Radiology, discusses the policy, which urges for more robust promotion of low-dose CT as a public health tool.
Angiographic catheters recalled due to safety risk
The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use.

The Cephea transcatheter mitral valve in development has been acquired by Medtronic.

Abbott acquires another TMVR device through purchase of Cephea

Abbott plans to acquire Cephea Valve Technologies, a company developing a transcatheter mitral valve replacement (TMVR) device, the Chicago-area healthcare giant announced Jan. 16.

FDA clears 1st imaging platform to select stroke patients for clot removal

The RAPID neuroimaging platform has been cleared by the FDA to use in selecting stroke patients for endovascular thrombectomy. It becomes the first imaging platform to receive such clearance for clot removal procedure, reported the creator of the technology, iSchemaView.

RAPID imaging platform cleared to select stroke patients for thrombectomy

The RAPID neuroimaging platform can now be used in the U.S. to select stroke patients who are likely to benefit from endovascular thrombectomy. It is the first imaging platform to be cleared by the FDA as a patient selection tool for this clot removal procedure, according to iSchemaView, which developed the technology.

RFPI receives FDA clearance to market iCertainty blood flow imaging device

GREENVILLE, N.C. — RFPi Inc. has received 510(k) clearance from the U.S. Food and Drug Administration to begin marketing for use by surgeons in open surgery its iCertainty™ blood flow and perfusion imaging medical device.

ACC releases new Appropriate Use Criteria for multimodality imaging of nonvalvular heart disease

The American College of Cardiology (ACC) and several other partnering societies, including the American Heart Association and American Society of Nuclear Cardiology, released on Monday, Jan. 7 its 2019 Appropriate Use Criteria (AUC) for multimodality imaging of nonvalvular heart disease.

SCCT shares updated guidance on CT use during TAVI, TAVR procedures

The Society of Cardiovascular Computed Tomography (SCCT) has issued an updated guidance for the use of CT in transcatheter aortic valve implantation (TAVI) and transcatheter aortic valve replacement (TAVR) procedures. The full document can be read in the Journal of Cardiovascular Computed Tomography.

Industry group releases new guidelines for CT use in TAVR procedures

The Society of Cardiovascular Computed Tomography (SCCT) released updated guidelines for using CT imaging in patients undergoing transcatheter aortic valve replacement (TAVR).

Neuroimaging researchers to study stroke recurrence risk with $3.2M grant

With a recently awarded $3.2 million R01 grant from the National Institute of Neurological Disorders and Stroke (NINDS), researchers at the University of Cincinnati (UC) in Ohio plan to study how neuroimaging can help pinpoint risk factors of stroke recurrence, according to a recent university press release.

Cardiac Imaging

AI turns low-quality MRI scans into helpful heart images

Johnson & Johnson MedTech faces threat of permanent injunction after losing antitrust case

Cardiologists, radiologists and surgeons share ‘landmark’ document on assessing prosthetic heart valves with CT

AMA resolution backs expanded low-dose CT screenings for lung cancer, heart risk

Angiographic catheters recalled due to safety risk